|
MRUS
|
Merus N.V.
|
US
|
NASDAQ
|
|
NEXI
|
NexImmune, Inc.
|
US
|
NASDAQ
|
|
PYXS
|
Pyxis Oncology, Inc.
|
US
|
NASDAQ
|
|
SLS
|
SELLAS Life Sciences Group, Inc.
|
US
|
NASDAQ
|
|
SNTI
|
Senti Biosciences, Inc.
|
US
|
NASDAQ
|
|
SYRS
|
Syros Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
TCBP
|
TC BioPharm (Holdings) plc
|
US
|
NASDAQ
|
|
VOR
|
Vor Biopharma Inc.
|
US
|
NASDAQ
|
|
XBIO
|
Xenetic Biosciences, Inc.
|
US
|
NASDAQ
|
|
RAC
|
Race Oncology Ltd
|
AU
|
ASX
|
|
ABSCF
|
Ab Science Paris
|
US
|
OTC
|
|
ARGNF
|
Argen X Nv
|
US
|
OTC
|
|
CMVLF
|
Cellectis Romainvil
|
US
|
OTC
|
|
OPHLY
|
Ono Pharmaceutical Co., Ltd
|
US
|
OTC
|
|
OTLC
|
Oncotelic Therapeutics, Inc
|
US
|
OTC
|
|
HEMO
|
Hemogenyx Pharmaceuticals Plc
|
UK
|
LSE
|
|
SAR
|
Sareum Holdings Plc
|
UK
|
LSE
|
|
HYL
|
Hyloris Developmentsen Sa
|
BE
|
BR
|
|
1T3
|
Syndax Pharmaceuticals Inc
|
DE
|
F
|
|
38I
|
Intellia Therapeutics Inc
|
DE
|
F
|